Patents by Inventor Lawrence A. Vincent

Lawrence A. Vincent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diazabicyclic compounds useful in the treatment of CNS and other disorders
    Patent number: 7442694
    Abstract: The present invention relates to a compounds of formula I: wherein A, B, D, E and F are defined herein; that are useful in treating central nervous system (CNS) diseases, disorders and conditions, such as but not limited to nicotine addiction, schizophrenia, depression, Alzheimer's disease, Parkinson's disease and ADHD. The present invention further comprises pharmaceutical compositions containing such compounds and methods of treatment comprising the use of such compounds.
    Type: Grant
    Filed: September 8, 2003
    Date of Patent: October 28, 2008
    Assignee: Pfizer Inc
    Inventors: Jotham W. Coe, Christopher J. O'Donnell, Brian T. O'Neill, Lawrence A. Vincent
  • Diazabicyclic compounds useful in the treatment of CNS and other disorders
    Publication number: 20040106603
    Abstract: The present invention relates to a compounds of formula I: 1
    Type: Application
    Filed: September 8, 2003
    Publication date: June 3, 2004
    Applicant: Pfizer Inc
    Inventors: Jotham W. Coe, Christopher J. O'Donnell, Brian T. O'Neill, Lawrence A. Vincent
  • Spiroazacyclic derivatives as substance P antagonists
    Patent number: 5688806
    Abstract: The present invention relates to novel spirocyclic piperidine derivatives and related compounds and, specifically, to compounds of the formula ##STR1## wherein X, Z, Y, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and m are as defined in the specification, and to intermediates used in the synthesis of such compounds. The novel compounds of formula I are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
    Type: Grant
    Filed: October 12, 1995
    Date of Patent: November 18, 1997
    Assignee: Pfizer Inc.
    Inventors: Manoj C. Desai, Lawrence A. Vincent